Literature DB >> 7777238

Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer.

C Carlomagno1, F Perrone, R Lauria, M de Laurentiis, C Gallo, A Morabito, G Pettinato, L Panico, T Bellelli, A Apicella.   

Abstract

We analyzed retrospectively the relationships and the prognostic significance of four anatomopathological features (elastosis, fibrosis, necrosis, inflammatory cell reaction) of the primary tumor in a series of 1,457 cases of infiltrating ductal carcinoma observed at our institution from January 1978 to December 1991. Necrosis, elastosis, fibrosis and inflammatory cell reaction were strongly associated among themselves (all p < 0.0001), the only exception being necrosis and elastosis. Necrosis was significantly related to tumor size (odds ratio [OR] = 5.40, p < 0.0001) and tumor grade (OR = 2.22, p < 0.0001). Univariate analysis showed that the presence of necrosis and cell reaction were significantly related to worse survival (p < 0.0001 and p = 0.03, respectively). Multivariate analysis, including the four variables plus nodal status, tumor size, grading, adjuvant therapy, age and first order interactions, revealed that greater tumor size (p < 0.0001), positive nodal status (p < 0.0001), higher histologic grade (p < 0.0001) and presence of inflammatory cell reaction (p = 0.0007) independently worsened survival. On the other hand, adjuvant therapy had a significant independent role in preventing deaths (p = 0.03). The only first-order interaction retained in the model was that between grading and cell reaction (p = 0.002). Cell reaction had a different prognostic behaviour in the groups G1-G2 and G3: in the former group, survival was worse (p = 0.0001) when the inflammatory cell reaction was present. In conclusion, we demonstrate that cell reaction is an independent prognostic factor in the G1-G2 subgroup of patients, and propose a hypothesis as to the role of cell reaction in primary breast cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7777238     DOI: 10.1159/000227472

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  12 in total

1.  The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells.

Authors:  Wei Bin Fang; Min Yao; Iman Jokar; Nabil Alhakamy; Cory Berkland; Jin Chen; Dana Brantley-Sieders; Nikki Cheng
Journal:  Breast Cancer Res Treat       Date:  2015-03-06       Impact factor: 4.872

2.  Predictive and prognostic significance of CD8+ tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy.

Authors:  Khalid Al-Saleh; Nashwa Abd El-Aziz; Arwa Ali; Waleed Abozeed; Ahmed Abd El-Warith; Ahmed Ibraheem; Jawaher Ansari; Ammar Al-Rikabi; Sufia Husain; Jean-Marc Nabholtz
Journal:  Oncol Lett       Date:  2017-05-10       Impact factor: 2.967

Review 3.  Matrix metalloproteinase inhibitors in the treatment of cancer.

Authors:  P D Brown
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

Review 4.  The recent progress of the mechanism and regulation of tumor necrosis in colorectal cancer.

Authors:  Xi Zhang; Lirong Chen
Journal:  J Cancer Res Clin Oncol       Date:  2015-06-21       Impact factor: 4.553

5.  CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.

Authors:  Shuzhen Liu; Jonathan Lachapelle; Samuel Leung; Dongxia Gao; William D Foulkes; Torsten O Nielsen
Journal:  Breast Cancer Res       Date:  2012-03-15       Impact factor: 6.466

6.  Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.

Authors:  Salomé S Pinho; Augusto J F Matos; Célia Lopes; Nuno T Marcos; Júlio Carvalheira; Celso A Reis; Fátima Gärtner
Journal:  BMC Cancer       Date:  2007-07-06       Impact factor: 4.430

7.  An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.

Authors:  Andrew E Teschendorff; Ahmad Miremadi; Sarah E Pinder; Ian O Ellis; Carlos Caldas
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

8.  Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.

Authors:  Maria Isabel Carvalho; Isabel Pires; Marlene Dias; Justina Prada; Hugo Gregório; Luis Lobo; Felisbina Queiroga
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-05       Impact factor: 2.916

9.  The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer.

Authors:  Z M A Mohammed; J J Going; J Edwards; B Elsberger; D C McMillan
Journal:  Br J Cancer       Date:  2013-08-27       Impact factor: 7.640

10.  Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis.

Authors:  Srikanth Nagalla; Jeff W Chou; Mark C Willingham; Jimmy Ruiz; James P Vaughn; Purnima Dubey; Timothy L Lash; Stephen J Hamilton-Dutoit; Jonas Bergh; Christos Sotiriou; Michael A Black; Lance D Miller
Journal:  Genome Biol       Date:  2013-04-29       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.